These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15885068)

  • 1. The Alzheimer disease-related calcium-binding protein Calmyrin is present in human forebrain with an altered distribution in Alzheimer's as compared to normal ageing brains.
    Bernstein HG; Blazejczyk M; Rudka T; Gundelfinger ED; Dobrowolny H; Bogerts B; Kreutz MR; Kuznicki J; Wojda U
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):314-24. PubMed ID: 15885068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
    Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
    Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain.
    Spiechowicz M; Bernstein HG; Dobrowolny H; Leśniak W; Mawrin C; Bogerts B; Kuźnicki J; Filipek A
    Neurochem Int; 2006 Oct; 49(5):487-93. PubMed ID: 16698122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-binding protein secretagogin-expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease.
    Attems J; Preusser M; Grosinger-Quass M; Wagner L; Lintner F; Jellinger K
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):23-32. PubMed ID: 17961140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ca2+-independent binding and cellular expression profiles question a significant role of calmyrin in transduction of Ca2+-signals to Alzheimer's disease-related presenilin 2 in forebrain.
    Blazejczyk M; Wojda U; Sobczak A; Spilker C; Bernstein HG; Gundelfinger ED; Kreutz MR; Kuznicki J
    Biochim Biophys Acta; 2006 Jan; 1762(1):66-72. PubMed ID: 16257512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of reelin-positive plaques is accompanied by a decline in basal forebrain projection neurons during normal aging.
    Madhusudan A; Sidler C; Knuesel I
    Eur J Neurosci; 2009 Sep; 30(6):1064-76. PubMed ID: 19735296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular distribution of insulin-like growth factor-II/mannose-6-phosphate receptor in normal human brain and its alteration in Alzheimer's disease pathology.
    Kar S; Poirier J; Guevara J; Dea D; Hawkes C; Robitaille Y; Quirion R
    Neurobiol Aging; 2006 Feb; 27(2):199-210. PubMed ID: 16399207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
    Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
    Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons.
    Attems J; Quass M; Gartner W; Nabokikh A; Wagner L; Steurer S; Arbes S; Lintner F; Jellinger K
    Exp Gerontol; 2007 Mar; 42(3):215-22. PubMed ID: 17116382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease.
    Arendt T; Brückner MK; Bigl V; Marcova L
    J Comp Neurol; 1995 Jan; 351(2):189-222. PubMed ID: 7535318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosome-associated membrane protein 1 (LAMP-1) in Alzheimer's disease.
    Barrachina M; Maes T; Buesa C; Ferrer I
    Neuropathol Appl Neurobiol; 2006 Oct; 32(5):505-16. PubMed ID: 16972884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished aromatase immunoreactivity in the hypothalamus, but not in the basal forebrain nuclei in Alzheimer's disease.
    Ishunina TA; van Beurden D; van der Meulen G; Unmehopa UA; Hol EM; Huitinga I; Swaab DF
    Neurobiol Aging; 2005 Feb; 26(2):173-94. PubMed ID: 15582747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
    Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
    J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of calbindin-D28k from aging human cholinergic basal forebrain: relation to neuronal loss.
    Geula C; Bu J; Nagykery N; Scinto LF; Chan J; Joseph J; Parker R; Wu CK
    J Comp Neurol; 2003 Jan; 455(2):249-59. PubMed ID: 12454989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference in expression of apoptosis-related proteins and apoptotic morphology in control, pathologically aged and Alzheimer's disease cases.
    Woodhouse A; Dickson TC; West AK; McLean CA; Vickers JC
    Neurobiol Dis; 2006 May; 22(2):323-33. PubMed ID: 16406795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presenilin-1 immunoreactivity is localized intracellularly in Alzheimer's disease brain, but not detected in amyloid plaques.
    Weber LL; Leissring MA; Yang AJ; Glabe CG; Cribbs DH; LaFerla FM
    Exp Neurol; 1997 Jan; 143(1):37-44. PubMed ID: 9000444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.